Preventing epilepsy after head injury and finding early warning signs
Translational Platform for Epilepsy Therapy and Biomarker Discovery
Trying a treatment that removes excess iron from the brain to stop epilepsy after head injury and to find early signals that show who’s at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-11307586 on NIH RePORTER |
What this research studies
This project uses a rigorous, multicenter preclinical approach to test whether an iron‑removing drug can prevent epilepsy that develops after a head injury. Researchers will use a standardized animal model of traumatic brain injury across four labs and run double‑blinded, randomized, vehicle‑controlled experiments to mirror clinical trial standards. They will also search for protein and other biomarkers and apply pharmacokinetic modeling and bioinformatics to identify early signals that predict who might develop epilepsy and who could benefit from treatment. The work builds on collaborations from the EpiBioS4Rx consortium and aims to move promising preclinical findings toward future human trials.
Who could benefit from this research
Good fit: People who recently had a moderate or severe head injury and are at risk of developing post‑traumatic epilepsy would be the future candidates for this work.
Not a fit: People with long‑standing epilepsy not caused by head injury or with primarily genetic epilepsies are unlikely to benefit from this specific approach.
Why it matters
Potential benefit: If successful, this could lead to treatments that prevent epilepsy after traumatic brain injury and tests that identify people who should receive them.
How similar studies have performed: Prior animal studies and preliminary data from the EpiBioS4Rx consortium suggest removing brain iron may reduce seizure development, but this approach has not yet been proven in humans.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Galanopoulou, Aristea S — Albert Einstein College of Medicine
- Study coordinator: Galanopoulou, Aristea S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.